Chinese General Practice ›› 2023, Vol. 26 ›› Issue (08): 997-1007.DOI: 10.12114/j.issn.1007-9572.2022.0535
Special Issue: 神经系统疾病最新文章合辑; 运动相关研究最新文章合辑; 脑健康最新研究合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:
2022-03-23
Revised:
2022-09-10
Published:
2023-03-15
Online:
2022-11-24
Contact:
TAN Jie, ZHAO Ning
通讯作者:
谭洁, 赵宁
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0535
步骤 | 检索式 |
---|---|
#1 | Transcranial Magnetic Stimulation[MeSH Terms] |
#2 | Repetitive Transcranial Magnetic Stimulation* OR theta burst stimulation OR TMS OR TBS |
#3 | #1 OR #2 |
#4 | Stroke[MeSH Terms] |
#5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke |
#6 | #4 OR #5 |
#7 | upper limb[MeSH Terms] |
#8 | upper limb movement dysfunction OR upper extremity motor dysfunction OR upper extremity movement dysfunction OR upper limb motor impairment |
#9 | #7 OR #8 |
#10 | randomized controlled trial[MeSH Terms] |
#11 | randomized controlled study OR randomized clinical trial OR controlled clinical Trial |
#12 | #10 OR #11 |
#13 | #3 AND #6 AND #9 AND #12 |
Table 1 Strategy for searching eligible systematic reviews included in PubMed database
步骤 | 检索式 |
---|---|
#1 | Transcranial Magnetic Stimulation[MeSH Terms] |
#2 | Repetitive Transcranial Magnetic Stimulation* OR theta burst stimulation OR TMS OR TBS |
#3 | #1 OR #2 |
#4 | Stroke[MeSH Terms] |
#5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke |
#6 | #4 OR #5 |
#7 | upper limb[MeSH Terms] |
#8 | upper limb movement dysfunction OR upper extremity motor dysfunction OR upper extremity movement dysfunction OR upper limb motor impairment |
#9 | #7 OR #8 |
#10 | randomized controlled trial[MeSH Terms] |
#11 | randomized controlled study OR randomized clinical trial OR controlled clinical Trial |
#12 | #10 OR #11 |
#13 | #3 AND #6 AND #9 AND #12 |
第一作者 | 发表时间(年) | 样本量(试验组/对照组) | 年龄(岁) | 性别(男/女) | 偏瘫侧(右/左) | 干预措施 | 结局指标 | ||
---|---|---|---|---|---|---|---|---|---|
试验组 | 对照组 | 试验组 | 对照组 | ||||||
肖长林[ | 2019 | 15/17 | 63.7±11.0 | 58.7±10.8 | 21/11 | 15/17 | HF-rTMS | 假刺激 | ①②③ |
梁绮婷[ | 2018 | 38/38a | 64.3±11.8 | 65.5±10.5 | 47/31 | — | HF-rTMS | 常规疗法 | ①③ |
周哲[ | 2020 | 30/28 | 59.7±10.4 | 61.8±11.4 | 41/17 | 28/30 | HF-rTMS | 假刺激 | ①②③ |
王玉琴[ | 2020 | 36/36 | 52.0±6.9 | 53.1±6.8 | 41/31 | 28/44 | LF-rTMS | 假刺激 | ①③④ |
刘阅[ | 2018 | 10/13 | 56.9±9.0 | 55.4±8.4 | 14/9 | 9/14 | LF-rTMS | 常规疗法 | ①②③ |
李冰洁[ | 2016 | 20/20 | 51.5±7.1 | 51.4±6.6 | 23/17 | 25/15 | LF-rTMS | 常规疗法 | ①③④ |
GOTTLIEB[ | 2021 | 14/14 | 63.9±10.9 | 62.4±11.5 | 12/16 | 8/20 | LF-rTMS | 假刺激 | ①② |
SENIÓW[ | 2012 | 20/20 | 63.5±8.9 | 63.4±9.2 | 26/14 | 23/17 | LF-rTMS | 假刺激 | ① |
汤昕未[ | 2018 | 8/8 | 53.8±10.8 | 55.6±14.6 | 14/2 | 14/2 | iTBS | 假刺激 | ①③ |
CHEN[ | 2019 | 11/11 | 52.9±11.1 | 52.6±8.3 | 14/8 | 15/7 | iTBS | 假刺激 | ①② |
CHEN[ | 2021 | 12/11 | 54.4±10.6 | 48.9±9.6 | 18/5 | 18/5 | iTBS | 假刺激 | ①② |
CHEN[ | 2021 | 16/16 | 57.4±8.0 | 51.4±9.2 | 7/25 | 13/19 | iTBS | 假刺激 | ③④ |
KUZU[ | 2021 | 7/6 | 61.3±9.8 | 65.3±4.6 | 8/5 | 8/5 | cTBS | 假刺激 | ①② |
CHA[ | 2021 | 20/20 | 67.6±7.2 | 69.1±6.0 | 25/15 | — | HF-rTMS | LF-rTMS | ① |
KONDO[ | 2017 | 71/32 | 62.3±12.5 | 60.0±14.2 | 73/30 | 47/56 | LF-rTMS | cTBS | ① |
孟祥民[ | 2016 | 14/17/14b | 57.4±13.3/55.1±12.9 | 51.2±14.1 | 33/12 | 30/15 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
LI[ | 2016 | 43/42/42b | 54.0±13.4/57.9±12.9 | 53.1±13.7 | 87/40 | 59/68 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
Table 2 Characteristics of the included studies
第一作者 | 发表时间(年) | 样本量(试验组/对照组) | 年龄(岁) | 性别(男/女) | 偏瘫侧(右/左) | 干预措施 | 结局指标 | ||
---|---|---|---|---|---|---|---|---|---|
试验组 | 对照组 | 试验组 | 对照组 | ||||||
肖长林[ | 2019 | 15/17 | 63.7±11.0 | 58.7±10.8 | 21/11 | 15/17 | HF-rTMS | 假刺激 | ①②③ |
梁绮婷[ | 2018 | 38/38a | 64.3±11.8 | 65.5±10.5 | 47/31 | — | HF-rTMS | 常规疗法 | ①③ |
周哲[ | 2020 | 30/28 | 59.7±10.4 | 61.8±11.4 | 41/17 | 28/30 | HF-rTMS | 假刺激 | ①②③ |
王玉琴[ | 2020 | 36/36 | 52.0±6.9 | 53.1±6.8 | 41/31 | 28/44 | LF-rTMS | 假刺激 | ①③④ |
刘阅[ | 2018 | 10/13 | 56.9±9.0 | 55.4±8.4 | 14/9 | 9/14 | LF-rTMS | 常规疗法 | ①②③ |
李冰洁[ | 2016 | 20/20 | 51.5±7.1 | 51.4±6.6 | 23/17 | 25/15 | LF-rTMS | 常规疗法 | ①③④ |
GOTTLIEB[ | 2021 | 14/14 | 63.9±10.9 | 62.4±11.5 | 12/16 | 8/20 | LF-rTMS | 假刺激 | ①② |
SENIÓW[ | 2012 | 20/20 | 63.5±8.9 | 63.4±9.2 | 26/14 | 23/17 | LF-rTMS | 假刺激 | ① |
汤昕未[ | 2018 | 8/8 | 53.8±10.8 | 55.6±14.6 | 14/2 | 14/2 | iTBS | 假刺激 | ①③ |
CHEN[ | 2019 | 11/11 | 52.9±11.1 | 52.6±8.3 | 14/8 | 15/7 | iTBS | 假刺激 | ①② |
CHEN[ | 2021 | 12/11 | 54.4±10.6 | 48.9±9.6 | 18/5 | 18/5 | iTBS | 假刺激 | ①② |
CHEN[ | 2021 | 16/16 | 57.4±8.0 | 51.4±9.2 | 7/25 | 13/19 | iTBS | 假刺激 | ③④ |
KUZU[ | 2021 | 7/6 | 61.3±9.8 | 65.3±4.6 | 8/5 | 8/5 | cTBS | 假刺激 | ①② |
CHA[ | 2021 | 20/20 | 67.6±7.2 | 69.1±6.0 | 25/15 | — | HF-rTMS | LF-rTMS | ① |
KONDO[ | 2017 | 71/32 | 62.3±12.5 | 60.0±14.2 | 73/30 | 47/56 | LF-rTMS | cTBS | ① |
孟祥民[ | 2016 | 14/17/14b | 57.4±13.3/55.1±12.9 | 51.2±14.1 | 33/12 | 30/15 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
LI[ | 2016 | 43/42/42b | 54.0±13.4/57.9±12.9 | 53.1±13.7 | 87/40 | 59/68 | HF-rTMS、LF-rTMS | 假刺激 | ①④ |
第一作者 | 刺激频率(Hz) | 刺激强度 | 总脉冲数 | 刺激部位 | 线圈类型 | 治疗方案及持续时间 |
---|---|---|---|---|---|---|
肖长林[ | 10 | 90% RMT | 900 | 患侧C3、C4 | "8"字形线圈 | 9 min/次,5次/周,持续2周 |
梁绮婷[ | 3 | 90%~120% AMT | 900 | 患侧C3、C4 | "8"字形线圈 | 20 min/次,持续治疗2周后休息2 d,持续8周 |
周哲[ | 5 | 80% RMT | 1 200 | 患侧M1 | "8"字形线圈 | 5 min/次,5次/周,持续3周 |
王玉琴[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续4周 |
刘阅[ | 1 | 90% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 24 min/次,5次/周,持续8周 |
李冰洁[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
GOTTLIEB[ | 1 | 100% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
SENIÓW[ | 1 | 90% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 30 min/次,5次/周,持续3周 |
汤昕未[ | 50-5 | 70% RMT | 600 | 患侧M1 | 圆形线圈 | 200 s/次,5次/周,持续2周 |
CHEN[ | 50-5 | 80% AMT | 600 | 患侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
CHEN[ | 50-5 | 80% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续3周 |
CHEN[ | 50-5 | 80% AMT | 600 | 患侧小脑 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
KUZU[ | 50-5 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
CHA[ | 10/1 | 90% RMT | 1 350/1 000 | 患侧M1/健侧M1 | "8"字形线圈 | 20 min/次,5次/周,持续2周 |
KONDO[ | 1/50-5 | 90% RMT/80% AMT | 2 400 | 运动皮质 | "8"字形线圈 | 20 min/次,6次/周,共2周;160 s/次,6次/周,共2周 |
孟祥民[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
LI[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
Table 3 rTMS parameters and treatment regimens in the included studies
第一作者 | 刺激频率(Hz) | 刺激强度 | 总脉冲数 | 刺激部位 | 线圈类型 | 治疗方案及持续时间 |
---|---|---|---|---|---|---|
肖长林[ | 10 | 90% RMT | 900 | 患侧C3、C4 | "8"字形线圈 | 9 min/次,5次/周,持续2周 |
梁绮婷[ | 3 | 90%~120% AMT | 900 | 患侧C3、C4 | "8"字形线圈 | 20 min/次,持续治疗2周后休息2 d,持续8周 |
周哲[ | 5 | 80% RMT | 1 200 | 患侧M1 | "8"字形线圈 | 5 min/次,5次/周,持续3周 |
王玉琴[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续4周 |
刘阅[ | 1 | 90% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 24 min/次,5次/周,持续8周 |
李冰洁[ | 1 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
GOTTLIEB[ | 1 | 100% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 10 min/次,5次/周,持续2周 |
SENIÓW[ | 1 | 90% RMT | 1 200 | 健侧M1 | "8"字形线圈 | 30 min/次,5次/周,持续3周 |
汤昕未[ | 50-5 | 70% RMT | 600 | 患侧M1 | 圆形线圈 | 200 s/次,5次/周,持续2周 |
CHEN[ | 50-5 | 80% AMT | 600 | 患侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
CHEN[ | 50-5 | 80% AMT | 1 200 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续3周 |
CHEN[ | 50-5 | 80% AMT | 600 | 患侧小脑 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
KUZU[ | 50-5 | 80% AMT | 600 | 健侧M1 | "8"字形线圈 | 200 s/次,5次/周,持续2周 |
CHA[ | 10/1 | 90% RMT | 1 350/1 000 | 患侧M1/健侧M1 | "8"字形线圈 | 20 min/次,5次/周,持续2周 |
KONDO[ | 1/50-5 | 90% RMT/80% AMT | 2 400 | 运动皮质 | "8"字形线圈 | 20 min/次,6次/周,共2周;160 s/次,6次/周,共2周 |
孟祥民[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
LI[ | 10/1 | 80% AMT | 1 350/1 000 | 健侧M1/患侧M1 | 圆形线圈 | 20 min/次,5次/周,持续2周 |
第一作者 | 随机方法 | 盲法 | 分配隐藏 | 结果数据的完整性 | 选择性报告研究结果 | 其他偏倚来源 |
---|---|---|---|---|---|---|
肖长林[ | 随机数字表 | 单盲 | 不清楚 | 有失访 | 否 | 不清楚 |
梁绮婷[ | 计算机随机 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
周哲[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
王玉琴[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
刘阅[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
李冰洁[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
GOTTLIEB[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
SENIÓW[ | 计算机随机 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
汤昕未[ | 计算机随机 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
CHEN[ | 计算机随机 | 单盲 | 有 | 无失访 | 否 | 不清楚 |
CHEN[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
CHEN[ | 随机数字表 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
KUZU[ | 计算机随机 | 双盲 | 不清楚 | 无失访 | 否 | 不清楚 |
CHA[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
KONDO[ | 不清楚 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
孟祥民[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
LI[ | 随机数字表 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
Table 4 Risk of bias of the included studies
第一作者 | 随机方法 | 盲法 | 分配隐藏 | 结果数据的完整性 | 选择性报告研究结果 | 其他偏倚来源 |
---|---|---|---|---|---|---|
肖长林[ | 随机数字表 | 单盲 | 不清楚 | 有失访 | 否 | 不清楚 |
梁绮婷[ | 计算机随机 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
周哲[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
王玉琴[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
刘阅[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
李冰洁[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
GOTTLIEB[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
SENIÓW[ | 计算机随机 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
汤昕未[ | 计算机随机 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
CHEN[ | 计算机随机 | 单盲 | 有 | 无失访 | 否 | 不清楚 |
CHEN[ | 计算机随机 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
CHEN[ | 随机数字表 | 双盲 | 不清楚 | 意向性分析 | 否 | 不清楚 |
KUZU[ | 计算机随机 | 双盲 | 不清楚 | 无失访 | 否 | 不清楚 |
CHA[ | 随机数字表 | 单盲 | 不清楚 | 无失访 | 否 | 不清楚 |
KONDO[ | 不清楚 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
孟祥民[ | 随机数字表 | 不清楚 | 不清楚 | 无失访 | 否 | 不清楚 |
LI[ | 随机数字表 | 双盲 | 不清楚 | 有失访 | 否 | 不清楚 |
干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
---|---|---|---|---|---|
LF-rTMS | -0.06(-0.37,0.24) | — | — | — | — |
iTBS | 0.24(-0.39,0.86) | 0.30(-0.31,0.92) | — | — | — |
cTBS | -0.06(-0.63,0.52) | 0.00(-0.50,0.51) | -0.30(-1.07,0.48) | — | — |
假刺激 | 0.47(0.17,0.78)a | 0.54(0.26,0.82)a | 0.24(-0.31,0.78) | 0.53(-0.02,1.09) | — |
常规疗法 | 0.66(0.21,1.10)a | 0.72(0.28,1.16)a | 0.42(-0.31,1.15) | 0.71(0.05,1.37)a | 0.18(-0.30,0.67) |
Table 5 Network meta-analysis of different modalities of rTMS intervention in increasing the FMA-UE score for stroke patients with upper limb motor dysfunction
干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
---|---|---|---|---|---|
LF-rTMS | -0.06(-0.37,0.24) | — | — | — | — |
iTBS | 0.24(-0.39,0.86) | 0.30(-0.31,0.92) | — | — | — |
cTBS | -0.06(-0.63,0.52) | 0.00(-0.50,0.51) | -0.30(-1.07,0.48) | — | — |
假刺激 | 0.47(0.17,0.78)a | 0.54(0.26,0.82)a | 0.24(-0.31,0.78) | 0.53(-0.02,1.09) | — |
常规疗法 | 0.66(0.21,1.10)a | 0.72(0.28,1.16)a | 0.42(-0.31,1.15) | 0.71(0.05,1.37)a | 0.18(-0.30,0.67) |
干预方案 | FMA-UE | MAS | MBI/BI | MEP潜伏期 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | |
HF-rTMS | 71.1 | 20.1 | 2.4 | 38.0 | 2.6 | 4.1 | 38.6 | 0 | 3.5 | 80.0 | 43.8 | 1.8 |
LF-rTMS | 79.9 | 29.2 | 2.0 | 64.1 | 14.7 | 2.8 | 96.4 | 85.6 | 1.1 | 78.9 | 33.2 | 1.8 |
iTBS | 45.8 | 9.8 | 3.7 | 77.0 | 45.5 | 2.1 | 74.9 | 14.4 | 2.0 | 24.9 | 2.1 | 4.0 |
cTBS | 75.3 | 40.9 | 2.2 | 61.0 | 31.0 | 2.9 | — | — | — | — | — | — |
假刺激 | 20.2 | 0 | 5.0 | 30.6 | 0.2 | 4.5 | 30.7 | 0 | 3.8 | 7.5 | 0 | 4.7 |
常规疗法 | 7.7 | 0 | 5.6 | 29.2 | 6.1 | 4.5 | 9.4 | 0 | 4.6 | 58.8 | 20.9 | 2.7 |
Table 6 SUCRA probabilities for the effectiveness of different modalities of rTMS intervention in stroke patients with upper limb motor dysfunction
干预方案 | FMA-UE | MAS | MBI/BI | MEP潜伏期 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | SUCRA值(%) | 最优概率(%) | 平均排序 | |
HF-rTMS | 71.1 | 20.1 | 2.4 | 38.0 | 2.6 | 4.1 | 38.6 | 0 | 3.5 | 80.0 | 43.8 | 1.8 |
LF-rTMS | 79.9 | 29.2 | 2.0 | 64.1 | 14.7 | 2.8 | 96.4 | 85.6 | 1.1 | 78.9 | 33.2 | 1.8 |
iTBS | 45.8 | 9.8 | 3.7 | 77.0 | 45.5 | 2.1 | 74.9 | 14.4 | 2.0 | 24.9 | 2.1 | 4.0 |
cTBS | 75.3 | 40.9 | 2.2 | 61.0 | 31.0 | 2.9 | — | — | — | — | — | — |
假刺激 | 20.2 | 0 | 5.0 | 30.6 | 0.2 | 4.5 | 30.7 | 0 | 3.8 | 7.5 | 0 | 4.7 |
常规疗法 | 7.7 | 0 | 5.6 | 29.2 | 6.1 | 4.5 | 9.4 | 0 | 4.6 | 58.8 | 20.9 | 2.7 |
干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
---|---|---|---|---|---|
LF-rTMS | -0.24(-0.94,0.45) | — | — | — | — |
iTBS | -0.50(-1.43,0.44) | -0.25(-1.26,0.75) | — | — | — |
cTBS | -0.28(-1.46,0.89) | -0.04(-1.28,1.20) | 0.21(-1.17,1.60) | — | — |
假刺激 | 0.05(-0.37,0.46) | 0.29(-0.27,0.85) | 0.54(-0.29,1.38) | 0.33(-0.77,1.43) | — |
常规疗法 | 0.14(-0.94,1.23) | 0.39(-0.45,1.22) | 0.64(-0.67,1.95) | 0.43(-1.06,1.92) | 0.10(-0.91,1.10) |
Table 7 Network meta-analysis of different rTMS intervention modalities in decreasing the MAS score in stroke patients with upper limb motor dysfunction
干预方案 | HF-rTMS | LF-rTMS | iTBS | cTBS | 假刺激 |
---|---|---|---|---|---|
LF-rTMS | -0.24(-0.94,0.45) | — | — | — | — |
iTBS | -0.50(-1.43,0.44) | -0.25(-1.26,0.75) | — | — | — |
cTBS | -0.28(-1.46,0.89) | -0.04(-1.28,1.20) | 0.21(-1.17,1.60) | — | — |
假刺激 | 0.05(-0.37,0.46) | 0.29(-0.27,0.85) | 0.54(-0.29,1.38) | 0.33(-0.77,1.43) | — |
常规疗法 | 0.14(-0.94,1.23) | 0.39(-0.45,1.22) | 0.64(-0.67,1.95) | 0.43(-1.06,1.92) | 0.10(-0.91,1.10) |
干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
---|---|---|---|---|
LF-rTMS | -0.87(-1.34,-0.39) | — | — | — |
iTBS | -0.48(-1.17,0.20) | 0.38(-0.33,1.10) | — | — |
假刺激 | 0.04(-0.33,0.41) | 0.91(0.49,1.33)a | 0.53(-0.05,1.10) | — |
常规疗法 | 0.23(-0.16,0.63) | 1.10(0.66,1.54)a | 0.72(-0.03,1.46) | 0.19(-0.28,0.66) |
Table 8 Network meta-analysis of different modalities of rTMS intervention in increasing the MBI and BI scores in stroke patients with upper limb motor dysfunction
干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
---|---|---|---|---|
LF-rTMS | -0.87(-1.34,-0.39) | — | — | — |
iTBS | -0.48(-1.17,0.20) | 0.38(-0.33,1.10) | — | — |
假刺激 | 0.04(-0.33,0.41) | 0.91(0.49,1.33)a | 0.53(-0.05,1.10) | — |
常规疗法 | 0.23(-0.16,0.63) | 1.10(0.66,1.54)a | 0.72(-0.03,1.46) | 0.19(-0.28,0.66) |
干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
---|---|---|---|---|
LF-rTMS | 0.02(-0.34,0.37) | — | — | — |
iTBS | 0.69(-0.10,1.48) | 0.68(-0.09,1.44) | — | — |
假刺激 | 0.91(0.55,1.28)a | 0.90(0.59,1.20)a | 0.22(-0.48,0.92) | — |
常规疗法 | 0.22(-0.51,0.94) | 0.20(-0.43,0.83) | -0.48(-1.47,0.52) | -0.70(-1.40,0) |
Table 9 Network meta-analysis of different rTMS intervention modalities in reducing the MEP latency in stroke patients with upper limb motor dysfunction
干预方案 | HF-rTMS | LF-rTMS | iTBS | 假刺激 |
---|---|---|---|---|
LF-rTMS | 0.02(-0.34,0.37) | — | — | — |
iTBS | 0.69(-0.10,1.48) | 0.68(-0.09,1.44) | — | — |
假刺激 | 0.91(0.55,1.28)a | 0.90(0.59,1.20)a | 0.22(-0.48,0.92) | — |
常规疗法 | 0.22(-0.51,0.94) | 0.20(-0.43,0.83) | -0.48(-1.47,0.52) | -0.70(-1.40,0) |
Figure 7 Corrected funnel plots for different rTMS intervention modalities in increasing the FMA-UE score in stroke patients with upper limb motor dysfunction
[1] |
孙海欣,王文志. 我国脑卒中流行状况及其防控策略[J]. 中华神经科杂志,2017,50(12):881-884. DOI:10.3760/cma.j.issn.1006-7876.2017.12.001.
|
[2] |
|
[3] |
|
[4] |
|
[5] | |
[6] |
|
[7] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国各类主要脑血管病诊断要点2019[J]. 中华神经科杂志,2019,52(9):710-715. DOI:10.3760/cma.j.issn.1006-7876.2019.09.003.
|
[8] |
李静,李幼平. 不断完善与发展的Cochrane系统评价[J]. 中国循证医学杂志,2008,8(9):742-743.
|
[9] |
肖长林,潘翠环,陈艳,等. 不同频率高频重复经颅磁刺激对缺血性脑卒中患者上肢功能的效果[J]. 中国康复理论与实践,2019,25(5):557-563. DOI:10.3969/j.issn.1006-9771.2019.05.011.
|
[10] |
梁绮婷,钟燕桃,施晓耕,等. 高频重复经颅磁刺激对脑卒中患者上肢运动及感觉功能的影响[J]. 中华老年心脑血管病杂志,2018,20(11):1187-1190. DOI:10.3969/j.issn.1009-0126.2018.11.016.
|
[11] |
周哲,沈夏锋,熊莉,等. 运动前区高频重复经颅磁刺激对脑卒中上肢功能康复的疗效[J]. 中国康复理论与实践,2020,26(6):697-702. DOI:10.3969/j.issn.1006-9771.2020.06.014.
|
[12] |
王玉琴,吕铭新,刘双洁,等. 高剂量低频健侧重复经颅磁刺激对脑梗死后上肢运动功能的影响[J]. 中国生物医学工程学报,2020,39(4):508-512. DOI:10.3969/j.issn.0258-8021.2020.04.015.
|
[13] |
刘阅,王晓阳,张长龙,等. 低频重复经颅磁刺激改善脑卒中后上肢痉挛的任务态功能磁共振研究[J]. 中国康复理论与实践,2018,24(7):828-833. DOI:10.3969/j.issn.1006-9771.2018.07.014.
|
[14] |
李冰洁,李芳,张通. 不同强度低频重复经颅磁刺激对脑卒中后上肢运动功能障碍的疗效[J]. 中国康复理论与实践,2016,22(9):1004-1007.
|
[15] |
|
[16] |
|
[17] |
汤昕未,胡瑞萍,朱玉连,等. 间歇性θ短阵脉冲刺激对脑卒中后运动功能障碍的影响[J]. 中国康复医学杂志,2018,33(12):1410-1415. DOI:10.3969/j.issn.1001-1242.2018.12.006.
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
孟祥民,赵宇阳,杨传美,等. 重复经颅磁刺激对脑梗死患者上肢运动功能的影响[J]. 中国康复医学杂志,2016,31(6):664-669. DOI:10.3969/j.issn.1001-1242.2016.06.010.
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
陈娟,林慈宽,程丽芳. 低频rTMS刺激联合早期康复运动对缺血性脑卒中患者运动、语言功能恢复的影响[J]. 海南医学,2021,32(15):1922-1925. DOI:10.3969/j.issn.1003-6350.2021.15.005.
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[1] | QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan. Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3422-3431. |
[2] | NIE Daning, SHI Shusheng, TAO Yuru. Clinical Effect of Proprioceptive Neuromuscular Facilitation Technique Combined with Spiral Stabilizing Muscle Chain Training in the Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3032-3042. |
[3] | LI Hao, LI Jiangtao, LIU Dan, WANG Jianjun. Efficacy and Safety of Belimumab, Anifrolumab, and Telitacicept on the Treatment of Systemic Lupus Erythematosus: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(23): 2924-2933. |
[4] | YANG Ji, ZHANG Yao, ZHAO Yingqiang, ZHANG Qiuyue. Evaluation of the Effectiveness of TCM Three-level Prevention and Control Model in the Management of Patients with Coronary Heart Disease and Stroke: a Single-center, Prospective Cohort Study [J]. Chinese General Practice, 2025, 28(22): 2750-2761. |
[5] | WEN Min, ZHOU Yongling, LIU Jingjing, JIANG Keqing, LIU Juan, ZHU Xiaodan. The Effect and Mechanism of Compensatory Cognitive Training Based on mHealth APP on Stable Schizophrenia Patients [J]. Chinese General Practice, 2025, 28(22): 2819-2825. |
[6] | TAN Yi, ZHU Lihong, YIN Zengwei, HOU Shunan, YU Houming. A Real-world Study of MRI-guided Intravenous Thrombolytic Therapy in Acute Ischemic Stroke [J]. Chinese General Practice, 2025, 28(20): 2508-2515. |
[7] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[8] | TAN Wenbin, LI Jia, LIU Mingyu, LU Yongxin, CHENG Yaxin. Research Progress on the Influence of Nervous System Diseases and Related Therapeutic Drugs on Osteoporosis [J]. Chinese General Practice, 2025, 28(17): 2092-2100. |
[9] | ZHU Shengjie, DIAO Huaqiong, HANG Xiaoyi, SUN Wenjun. Network Meta-analysis of Different Traditional Chinese Medicine Injections for the Treatment of Posterior Circulatory Ischemic Vertigo [J]. Chinese General Practice, 2025, 28(14): 1795-1808. |
[10] | LI Mei, JIANG Dongsheng, ZHAO Jingjing, CAO Yajing, ZHANG Fan, TANG Lijuan, LIU Xiaoli. Correlation Analysis of Homocysteine and Stroke in People over 40 Years Old [J]. Chinese General Practice, 2025, 28(14): 1723-1729. |
[11] | CHI Xun, LIU Sisi, CHEN Qiao, HU Yue, WANG Weixian. The Suitability of Four Nutritional Screening Tools for Nutritional Screening in Patients with Cirrhosis: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(11): 1395-1402. |
[12] | ZHAO Zhixin, MEI Yongxia, WANG Xiaoxuan, JIANG Hu, WANG Wenna, ZHANG Zhenxiang. Cognition and Experience of Social Participation in Stroke Survivors: a Meta-synthesis Based on Qualitative Studies [J]. Chinese General Practice, 2025, 28(10): 1273-1280. |
[13] | GU Mingyu, QIN Tingting, QIAO Kun, BAI Xinyuan, WANG Yao, YANG Yutong, LI Xingming. A Network Meta-analysis of Primary Hypertension Management Patterns in China [J]. Chinese General Practice, 2025, 28(10): 1265-1272. |
[14] | LIU Zuting, XU Minghuan, YANG Xuezhi, MO Jiali, LIU Xingyu, DU Huijie, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between the Systemic Inflammatory Response Index and Risk of Ischemic Stroke Recurrence [J]. Chinese General Practice, 2025, 28(05): 541-547. |
[15] | DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||